Why GlycoMimetics Stock Is Trading Higher Monday
Why GlycoMimetics Stock Is Trading Higher Monday
GlycoMimetics, Inc. (NASDAQ:GLYC) stock is moving higher Monday after its chief medical officer disclosed the purchase of company stock.
週一，GlycoMimetics, Inc.（納斯達克：GLYC）股票價格上漲，因其首席醫療官披露購買公司股票。
The Details: On Tuesday, the chief medical officer Edwin Rock disclosed in a Form4 that he bought 305,000 shares of the company.
詳情如下：週二，首席醫療官Edwin Rock在Form4中披露，他購買了公司的305,000股股票。
Rock purchased the shares at an average price of 26 cents.
Rock以每股26美分的平均價格購買了這些股票。
How To Buy GlycoMimetics Stock
如何購買GlycoMimetics的股票
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like GlycoMimetics's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投資者在決定股票是否值得買入時，可以做出一些決策。除了估值和價格走勢這些你可以在Benzinga的股票報價頁面上找到的指標之外，還有是否發放股息或每個季度買入其大量股票等因素。
These are known as capital allocation programs. GlycoMimetics (NASDAQ:GLYC) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
這些因素被稱爲資本配置計劃。GlycoMimetics（納斯達克：GLYC）不發放股息，但顯然有幾種方式可以回報股東。可以在Benzinga的股息日曆中搜索即將發放股息的公司，確定持有公司股票可以賺取多少收益率。
For example, if you're looking to earn an annualized return of 21.91%, you'll need to buy a share of Simplify Exchange Traded Funds Simplify Propel Opportunities ETF by the Jun. 25, 2024. Once done, you can expect to receive a nominal payout of $1.25 on Jun. 28, 2024.
例如，如果您想獲得21.91％的年化回報率，則需要在2024年6月25日之前買入一份Simplify Exchange Traded Funds Simplify Propel Opportunities ETF的股票。完成後，您可以在2024年6月28日收到1.25美元的名義賠付。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on GlycoMimetics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回購計劃顯然是不同的且高度可變的。公司可以批准回購計劃，並根據其認爲適當的時期購買股票。查看GlycoMimetics的最新消息通常會了解公司是否最近批准了回購計劃。股票回購計劃通常用作支撐股價的壓力位。
Related Link: 5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
相關鏈接：本週的5支生物科技股：默沙東，Intellia，Verona和更多
GLYC Price Action: At the time of publication, GlycoMimetics shares is trading 20% higher at 32 cents, according to data from Benzinga Pro.
GLYC股票價格爲32美分，上漲20％，數據來自Benzinga Pro。
Image: 8676549 from Pixabay.
圖片來源：來自Pixabay的8676549。
譯文內容由第三人軟體翻譯。